BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 24958099)

  • 1. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.
    Meakin PJ; Chowdhry S; Sharma RS; Ashford FB; Walsh SV; McCrimmon RJ; Dinkova-Kostova AT; Dillon JF; Hayes JD; Ashford ML
    Mol Cell Biol; 2014 Sep; 34(17):3305-20. PubMed ID: 24958099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Li J; Sapper TN; Mah E; Rudraiah S; Schill KE; Chitchumroonchokchai C; Moller MV; McDonald JD; Rohrer PR; Manautou JE; Bruno RS
    Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2.
    Bathish B; Robertson H; Dillon JF; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2022 Aug; 188():221-261. PubMed ID: 35728768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
    Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
    Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
    Cui Y; Wang Q; Li X; Zhang X
    Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.
    Lee LY; Köhler UA; Zhang L; Roenneburg D; Werner S; Johnson JA; Foley DP
    Toxicol Sci; 2014 Dec; 142(2):361-74. PubMed ID: 25294219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice.
    Kawaguchi T; Ueno T; Nogata Y; Hayakawa M; Koga H; Torimura T
    Int J Mol Med; 2017 Feb; 39(2):407-414. PubMed ID: 28000843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
    Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
    J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
    Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet.
    Okada K; Warabi E; Sugimoto H; Horie M; Gotoh N; Tokushige K; Hashimoto E; Utsunomiya H; Takahashi H; Ishii T; Yamamoto M; Shoda J
    J Gastroenterol; 2013 May; 48(5):620-32. PubMed ID: 22972520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.